eXalt3 trial findings indicate ensartinib may improve progression-free survival for patients with advanced ALK-rearranged non-small-cell lung cancer

CheckMate 743 results favour nivolumab plus ipilimumab over chemotherapy for treatment-naïve patients with inoperable malignant pleural mesothelioma

Adding sintilimab to pemetrexed plus platinum may improve progression-free survival for advanced nonsquamous non-small-cell lung cancer patients

Early results suggest benefit of dual PARP and PD-L1 inhibition in metastatic breast cancer patients carrying germline BRCA mutations

Analysis of a phase III study highlights the prognostic value of molecular classification in high-risk endometrial cancer

Patients with locoregionally advanced squamous cell carcinoma of the head and neck could benefit from the addition of the apoptosis inhibitor antagonist Debio 1143 to first-line chemoradiotherapy

Phase II data point to durable responses with combination immunotherapy in certain subsets of advanced biliary tract cancers

Restrictive measures to control the spread of COVID-19 have adverse effect on continuation of radiotherapy in patients with cancer